Multiparametric Assessment to Investigate Prognostic Factors for Disease Evolution a nd Evolutionary Patterns of Cognitive Status in RRMS
Multiparametric Clinical, Radiological, Neuropsychological, and Neurophysiological Assessment to Investigate Prognostic Factors for Disease Evolution and Treatment Response in MS: a Prospective Study.
University Hospital of Mont-Godinne
50 participants
Jun 6, 2022
INTERVENTIONAL
Conditions
Summary
This prospective study combining non conventional MRI techniques, neuropsychological screening tools, and a neurophysiological work-up using a sensitive and validated battery, will evaluate the predictive value of these measures and will explore the changes of the cognitive scores from baseline.
Eligibility
Inclusion Criteria6
- active MS, according to the Lublin criteria
- disease duration \< 10 years before initiating or changing a disease-modifying therapies,
- relapse- and steroid-free for at least 1 month before MRI acquisition
- between 18-50 years old
- having given informed consent
- with no significant comorbidity other than MS or substance abuse that could interfere with cognitive performances
Exclusion Criteria1
- progressive forms of MS
Interventions
neuropsychological assessment, PRO measures, non-conventional MRI metrics
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05510817